These findings suggest a potential connection between LOX-regulated macrophages and CD8+ T cells in GBM, which promoted us to explore the role of LOX inhibition in regulating antitumor immune responses in PTEN-deficient GBM mouse models. The gene discussed is CD8A; the disease is glioblastoma.